BlackRock Fund Advisors’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$17K	Buy	420 +5	+1%	+$202	﹤0.01%	3899
2016 Q3	$29K	Sell	415 -5	-1%	-$349	﹤0.01%	3848
2016 Q2	$27K	Buy	+420	New	+$27K	﹤0.01%	3878